TOCKiso-40-SR
Description_Effects
TOCKiso-40 SR contains Isoxsuprine Hydrochloride 40 mg in a sustained-release (SR) formulation. It is a beta-adrenergic agonist primarily used in the management of conditions associated with uterine muscle contractions and poor blood circulation. The medicine works by relaxing the smooth muscles of the uterus, helping prevent premature labor, especially in women with a history of early contractions or threatened miscarriage. By reducing uterine muscle activity, it supports a healthier and more stable pregnancy, particularly in high-risk cases. Additionally, Isoxsuprine acts as a vasodilator, meaning it widens the blood vessels, especially in the limbs and brain. This improved blood flow can help treat peripheral vascular diseases such as Raynaud’s disease, Buerger’s disease, or cerebrovascular insufficiency, conditions where narrowed blood vessels lead to poor circulation. By enhancing circulation, it reduces symptoms like numbness, cold extremities, and leg cramps. TOCKiso-40 SR should be taken exactly as prescribed by the doctor. The sustained-release design ensures a steady release of medication over time, maintaining consistent therapeutic levels in the body. It should not be discontinued abruptly without consulting your healthcare provider. Common side effects may include flushing, low blood pressure, or dizziness. Always inform your doctor about other medications you’re taking to avoid potential interactions.
